CDDO-3P-Im

HY-135953

CDDO-3P-Im

CDDO-3P-Im is an analogue of CDDO-Imidazolide with chemopreventive effect. CDDO-3P-Im can reduce the size and the severity of the lung tumors in mouse lung cancer model[1]. CDDO-3P-Im is a orally active necroptosis inhibitor that can be used for the research of ischemia/reperfusion (I/R)[2].

389.68 €

MBS5754261-25mg

CDDO-3P-Im

1421.75 €

MBS5754261-5x25mg

CDDO-3P-Im

5559.12 €

C4354-10

CDDO-TFEA

Apoptosis|KEAP1-Nrf2

993.8 €

C4354-5

CDDO-TFEA

Apoptosis|KEAP1-Nrf2

615.8 €

HY-112671

CDDO-dhTFEA

CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB[1]. CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats[2].

1324.76 €